NYSE$PHR
Phreesia Inc · Q2 2025 earnings
Q2 2025 earnings · · Investor relations
Briefing
Phreesia's financial performance improved, with revenue increasing and the company achieving positive free cash flow.
Phreesia announced its Q2 Fiscal Year 2025 results, highlighting a 19% year-over-year increase in total revenue to $102.1 million and the achievement of positive free cash flow. The company is maintaining its revenue outlook for fiscal 2025 and updating its Adjusted EBITDA outlook.
- Total revenue increased by 19% year-over-year, reaching $102.1 million.
- Average number of healthcare services clients (AHSCs) increased by 21% year-over-year, reaching 4,169.
- Free cash flow was $3.7 million, compared to negative $15.2 million in the same period of the prior year.
- Net loss decreased to $18.0 million, compared to a net loss of $36.8 million in the same period of the prior year.
Headline financials
Revenue & EPS history
Phreesia · Revenue · Quarterly
$102M
Revenue by segment
Phreesia · $91.6M total across 3 segments · Q3 2024
- Subscription Services$42.6M+29.1%46.5%
- Network Solutions$25.8M+26.0%28.2%
- Payment Processing$23.2M+18.3%25.3%
Forward guidance
Phreesia is maintaining its revenue outlook for fiscal year 2025 and updating its Adjusted EBITDA outlook.
Tailwinds
- Maintaining revenue outlook for fiscal 2025 of $416 million to $426 million, implying year-over-year growth of 17% to 20%.
- Updating Adjusted EBITDA outlook for fiscal 2025 to a range of $26 million to $31 million from a previous range of $21 million to $26 million.
- Expect AHSCs to reach approximately 4,200 for fiscal 2025 compared to 3,601 for fiscal 2024.
- Expect Total revenue per AHSC to increase in fiscal 2025 compared to the $98,944 achieved in fiscal 2024.
- Believe that the company's cash and cash equivalents, along with cash generated in normal operations, provide sufficient flexibility to reach fiscal 2025 and fiscal 2026 outlook.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q2 2025
-1.6%
Avg return
Earnings day
+2.5%
Avg return
5 days after
+2.0%
Avg return
30 days after
54%
15 / 28 earnings
Positive
+21.4%
Q2 2023
Best reaction
-26.3%
Q4 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | -26.3% | -1.1% | — | |
| Q1 2027 | +2.3% | +13.3% | — | |
| Q3 2026 | -22.8% | -19.2% | -16.0% | |
| Q2 2026 | -9.8% | -18.8% | -25.4% | |
| Q1 2026 | -6.6% | -0.2% | +14.2% | |
| Q4 2025 | +6.9% | +14.6% | +1.1% | |
| Q3 2025 | +11.1% | +14.8% | +30.8% | |
| Q2 2025 | +7.9% | +0.5% | -6.8% | |
| Q1 2025 | -13.3% | -14.7% | -2.9% | |
| Q4 2024 | +1.7% | -0.7% | +1.0% | |
| Q3 2024 | +17.8% | +18.8% | +45.2% | |
| Q2 2024 | -21.2% | -27.1% | -39.1% | |
| Q1 2024 | +3.6% | +10.3% | +4.0% | |
| Q4 2023 | -13.5% | -10.0% | -5.7% | |
| Q3 2023 | +18.7% | +34.8% | +20.0% | |
| Q2 2023 | +21.4% | +28.2% | +4.9% | |
| Q1 2023 | +11.9% | +17.5% | +40.1% | |
| Q4 2022 | -11.9% | +1.3% | -23.6% | |
| Q3 2022 | -20.2% | -20.9% | -32.9% | |
| Q2 2022 | -12.4% | -6.2% | -15.4% | |
| Q1 2022 | +6.6% | +12.7% | +24.2% | |
| Q4 2021 | +2.5% | +8.4% | +3.3% | |
| Q3 2021 | +7.3% | +18.1% | +16.2% | |
| Q2 2021 | -3.2% | -9.2% | +3.5% | |
| Q1 2021 | -6.7% | -10.5% | -13.1% | |
| Q4 2020 | +4.2% | +18.1% | +30.6% | |
| Q3 2020 | -1.0% | -8.8% | -6.9% | |
| Q2 2020 | +0.2% | +7.3% | +1.2% | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro